COMMON STOCK PURCHASE WARRANT Fortress biotech, inc.Security Agreement • September 23rd, 2024 • Fortress Biotech, Inc. • Pharmaceutical preparations • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its registered assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after September [●], 2024 (the “Initial Exercise Date”1) and on or prior to 5:00 p.m. (New York City time) on March [●], 2030 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Fortress Biotech, Inc., a Delaware corporation (the “Company”), up to ______ shares of Common Stock (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 23rd, 2024 • Fortress Biotech, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of September [∙], 2024, between Fortress Biotech, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
Placement Agency AgreementPlacement Agency Agreement • September 23rd, 2024 • Fortress Biotech, Inc. • Pharmaceutical preparations • New York
LOCK-UP AGREEMENTLock-Up Agreement • September 23rd, 2024 • Fortress Biotech, Inc. • Pharmaceutical preparations
